24 May 2013
Keywords: merck, co, alnylam, sign, deal, firms, pharmaceuticals
Article | 05 July 2004
US firms Merck & Co and Alnylam Pharmaceuticals have entered into amulti-year agreement to develop and commercialize RNAi therapeutics for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2004
23 May 2013
© 2013 thepharmaletter.com